Literature DB >> 24323991

Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia".

Chiara Palmi1, Tobia Lana, Daniela Silvestri, Angela Savino, Geertruy Te Kronnie, Valentino Conter, Giuseppe Basso, Andrea Biondi, Maria Grazia Valsecchi, Giovanni Cazzaniga.   

Abstract

Entities:  

Keywords:  IKZF1 deletions; copy number abnormalities; pediatric Ph- BCP-ALL; prognosis

Mesh：

Substances：

Year:  2013        PMID： 24323991      PMCID： PMC3856981          DOI： 10.3324/haematol.2013.099077

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  9 in total

Review 1.  Antigen receptor allelic exclusion: an update and reappraisal.

Authors:  Brenna L Brady; Natalie C Steinel; Craig H Bassing
Journal:  J Immunol       Date:  2010-10-01       Impact factor: 5.422

2.  Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia.

Authors:  C Palmi; E Vendramini; D Silvestri; G Longinotti; D Frison; G Cario; C Shochat; M Stanulla; V Rossi; A M Di Meglio; T Villa; E Giarin; G Fazio; A Leszl; M Schrappe; G Basso; A Biondi; S Izraeli; V Conter; M G Valsecchi; G Cazzaniga; G Te Kronnie
Journal:  Leukemia       Date:  2012-04-09       Impact factor: 11.528

3.  Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.

Authors:  Richard C Harvey; Charles G Mullighan; Xuefei Wang; Kevin K Dobbin; George S Davidson; Edward J Bedrick; I-Ming Chen; Susan R Atlas; Huining Kang; Kerem Ar; Carla S Wilson; Walker Wharton; Maurice Murphy; Meenakshi Devidas; Andrew J Carroll; Michael J Borowitz; W Paul Bowman; James R Downing; Mary Relling; Jun Yang; Deepa Bhojwani; William L Carroll; Bruce Camitta; Gregory H Reaman; Malcolm Smith; Stephen P Hunger; Cheryl L Willman
Journal:  Blood       Date:  2010-08-10       Impact factor: 22.113

4.  What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?

Authors:  Chiara Palmi; Maria Grazia Valsecchi; Giulia Longinotti; Daniela Silvestri; Valentina Carrino; Valentino Conter; Giuseppe Basso; Andrea Biondi; Geertruy Te Kronnie; Giovanni Cazzaniga
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

5.  Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia.

Authors:  Aurélie Caye; Kheïra Beldjord; Kelly Mass-Malo; Séverine Drunat; Jean Soulier; Virginie Gandemer; André Baruchel; Yves Bertrand; Hélène Cavé; Emmanuelle Clappier
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

6.  BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.

Authors:  Charles G Mullighan; Christopher B Miller; Ina Radtke; Letha A Phillips; James Dalton; Jing Ma; Deborah White; Timothy P Hughes; Michelle M Le Beau; Ching-Hon Pui; Mary V Relling; Sheila A Shurtleff; James R Downing
Journal:  Nature       Date:  2008-04-13       Impact factor: 49.962

7.  A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.

Authors:  Monique L Den Boer; Marjon van Slegtenhorst; Renée X De Menezes; Meyling H Cheok; Jessica G C A M Buijs-Gladdines; Susan T C J M Peters; Laura J C M Van Zutven; H Berna Beverloo; Peter J Van der Spek; Gaby Escherich; Martin A Horstmann; Gritta E Janka-Schaub; Willem A Kamps; William E Evans; Rob Pieters
Journal:  Lancet Oncol       Date:  2009-01-08       Impact factor: 41.316

8.  Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; Xiaoping Su; Jinghui Zhang; Ina Radtke; Letha A A Phillips; Christopher B Miller; Jing Ma; Wei Liu; Cheng Cheng; Brenda A Schulman; Richard C Harvey; I-Ming Chen; Robert J Clifford; William L Carroll; Gregory Reaman; W Paul Bowman; Meenakshi Devidas; Daniela S Gerhard; Wenjian Yang; Mary V Relling; Sheila A Shurtleff; Dario Campana; Michael J Borowitz; Ching-Hon Pui; Malcolm Smith; Stephen P Hunger; Cheryl L Willman; James R Downing
Journal:  N Engl J Med       Date:  2009-01-07       Impact factor: 91.245

9.  IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan.

Authors:  Daisuke Asai; Toshihiko Imamura; So-ichi Suenobu; Akiko Saito; Daiichiro Hasegawa; Takao Deguchi; Yoshiko Hashii; Kimikazu Matsumoto; Hirohide Kawasaki; Hiroki Hori; Akihiro Iguchi; Yoshiyuki Kosaka; Koji Kato; Keizo Horibe; Keiko Yumura-Yagi; Junichi Hara; Megumi Oda
Journal:  Cancer Med       Date:  2013-05-09       Impact factor: 4.452
  9 in total
  7 in total

1.  Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study.

Authors:  J M Boer; A van der Veer; D Rizopoulos; M Fiocco; E Sonneveld; H A de Groot-Kruseman; R P Kuiper; P Hoogerbrugge; M Horstmann; M Zaliova; C Palmi; J Trka; E Fronkova; M Emerenciano; M do Socorro Pombo-de-Oliveira; W Mlynarski; T Szczepanski; K Nebral; A Attarbaschi; N Venn; R Sutton; C J Schwab; A Enshaei; A Vora; M Stanulla; M Schrappe; G Cazzaniga; V Conter; M Zimmermann; A V Moorman; R Pieters; M L den Boer
Journal:  Leukemia       Date:  2015-07-23       Impact factor: 11.528

Review 2.  Genomics in acute lymphoblastic leukaemia: insights and treatment implications.

Authors:  Kathryn G Roberts; Charles G Mullighan
Journal:  Nat Rev Clin Oncol       Date:  2015-03-17       Impact factor: 66.675

3.  IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.

Authors:  E Clappier; N Grardel; M Bakkus; J Rapion; B De Moerloose; P Kastner; A Caye; J Vivent; V Costa; A Ferster; P Lutz; F Mazingue; F Millot; D Plantaz; G Plat; E Plouvier; M Poirée; N Sirvent; A Uyttebroeck; K Yakouben; S Girard; N Dastugue; S Suciu; Y Benoit; Y Bertrand; H Cavé
Journal:  Leukemia       Date:  2015-06-08       Impact factor: 11.528

4.  Expression of Ik6 and Ik8 Isoforms and Their Association with Relapse and Death in Mexican Children with Acute Lymphoblastic Leukemia.

Authors:  Adriana Reyes-León; Rocío Juárez-Velázquez; Alma Medrano-Hernández; Teresa Cuenca-Roldán; Consuelo Salas-Labadía; María Del Pilar Navarrete-Meneses; Roberto Rivera-Luna; Gerardo López-Hernández; Rogelio Paredes-Aguilera; Patricia Pérez-Vera
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

5.  Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia.

Authors:  C Vesely; C Frech; C Eckert; G Cario; A Mecklenbräuker; U Zur Stadt; K Nebral; F Kraler; S Fischer; A Attarbaschi; M Schuster; C Bock; H Cavé; A von Stackelberg; M Schrappe; M A Horstmann; G Mann; O A Haas; R Panzer-Grümayer
Journal:  Leukemia       Date:  2016-11-30       Impact factor: 11.528

6.  Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes.

Authors:  Monica Messina; Sabina Chiaretti; Jiguang Wang; Anna Lucia Fedullo; Nadia Peragine; Valentina Gianfelici; Alfonso Piciocchi; Fulvia Brugnoletti; Filomena Di Giacomo; Simona Pauselli; Antony B Holmes; Maria Cristina Puzzolo; Giulia Ceglie; Valerio Apicella; Marco Mancini; Geertruy Te Kronnie; Anna Maria Testi; Antonella Vitale; Marco Vignetti; Anna Guarini; Raul Rabadan; Robin Foà
Journal:  Oncotarget       Date:  2016-03-22

Review 7.  Genomic Analyses of Pediatric Acute Lymphoblastic Leukemia Ph+ and Ph-Like-Recent Progress in Treatment.

Authors:  Agnieszka Kaczmarska; Patrycja Śliwa; Joanna Zawitkowska; Monika Lejman
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.